Avertto

Avertto is revolutionizing the hospitals and healthcare industry with its cutting-edge medical device technology. Focused on proactive health solutions, Avertto has developed an innovative insertable device designed with AI capabilities to detect and alert healthcare providers of impending strokes. This technology aims to significantly improve patient outcomes by enabling timely interventions and preventing neurological damage. With a commitment to changing the standard of care, Avertto is dedicated to making lives worth living longer.

Avertto's unique, patented, subcutaneous telemonitoring medical device employs advanced AI and signal analysis to monitor changes in carotid pulse waves. The device sends timely alerts, facilitating early treatment and potentially mitigating the debilitating effects of stroke. Located at House 1037, Aderet, N/A 9985000, IL, Avertto is strategically positioned to address the critical need for effective stroke prevention and management in the healthcare sector.

Avertto's hybrid go-to-market strategy, which includes in-patient clinical studies and a rigorous regulatory pathway, is designed to facilitate large-scale adoption. With ongoing clinical studies at multiple sites across Israel, Spain, and the USA, Avertto is poised to transform stroke care. We invite the manager of Avertto to create a customized and exclusive company showcase and product listing on our platform to further highlight its innovative solutions and drive commercial growth.